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TO THE EDITOR
In 2002, unique cytoplasmic compart-
ments were identified and termed GW
bodies (GWBs), also known as mam-
malian processing bodies (P bodies)
(Eystathioy et al., 2002; van Dijk
et al., 2002; Sheth and Parker, 2003;
Eulalio et al., 2007; Jakymiw et al.,
2007; Parker and Sheth, 2007). GWBs
were named after the GW182 protein,
an mRNA-binding protein that resides
within these macromolecular foci
(Eystathioy et al., 2002). Characteriza-
tion of this protein revealed numerous
GW (glycine–tryptophan) repeats and
a canonical RNA recognition motif
(Eystathioy et al., 2002). The GW182
protein associates with a specific subset
of mRNA, serves as a scaffold or matrix
protein, and helps to maintain the
integrity of GWBs as knock down of
the GW182 protein results in a loss of
GWBs (Jakymiw et al., 2005, 2007).
GWBs contain a defined subset of
mRNA, microRNA, and various proteins
involved in mRNA degradation and
RNA interference (RNAi) (Eystathioy
et al., 2003; Andrei et al., 2005;
Jakymiw et al., 2005; Liu et al.,
2005a, b; Rehwinkel et al., 2005;
Behm-Ansmant et al., 2006; Pauley
et al., 2006; Valencia-Sanchez et al.,
2006). Intact GWBs are also found to be
critical to the RNAi pathway, and
microRNA is critical in the formation
of GWBs (Jakymiw et al., 2005; Pauley
et al., 2006). Lastly, GWBs have been
shown to interact with stress granules
during cellular stress responses (Keder-
sha et al., 2005). Current research has
focused on improving our understanding
of the structure and function of GWBs in
a variety of cells and tissues during
embryonic development, physiological
responses, neoplastic transformation,
and aging. As these structures function
to localize specific subsets of mRNA and
microRNAs, degrade mRNAs, interact
with stress granules during the stress
response, and are differentially regulated
during the cell cycle and cell prolifera-
tion, GWBs may serve as important
regulatory sites for normal, inflamma-
tory, and malignant skin disease.
To investigate the presence and dis-
tribution patterns of GWBs in normal
human skin, 8-mm-thick paraffin-em-
bedded normal skin sections were trea-
ted with an antigen retrieval method and
stained with mouse mAbs to the recom-
binant GW182 protein as previously
described (Jakymiw et al., 2005). In the
epidermis and cutaneous appendages,
GWBs were most prominent in the
stratum basale and the outer root sheath
of the hair follicle (Figure 1a–d). The
GWBs visualized in these structures
were generally larger and more numer-
ous than in other cutaneous structures.
In the epidermis, they were predomi-
nantly located in a single row along the
basal layer, although transverse sections
revealed several layers of keratinocytes
containing GWBs in the deep rete
ridges. Colocalization studies with a
rabbit polyclonal antibody to keratin
15 (ProteinTech Group Inc, Chicago,
IL) confirmed the follicular localization
of GWBs to bulge progenitor cells (Lyle
et al., 1998; Morris et al., 2004;
Ohyama et al., 2006) (Figure S1). GW
bodies were also visualized in the
basaloid cells of the sebaceous glands
and the eccrine glands (Figure S2). The
germinative matrix of the hair bulb
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Figure 1. Cytoplasmic GW bodies are present in the proliferative compartments of normal human skin
and in a normal human epidermal keratinocyte (NHEK) cell line.Mouse monoclonal anti-GW182 antibodies
(green) were used to carry out indirect immunofluorescence (IIF) studies on normal human skin. GWBs
were localized to the stratum basale (a) and the outer root sheath (ORS) of the hair follicle (c). Controls using
only secondary antibody are shown for the stratum basale (b) and the ORS of the hair follicle (d). The dotted
scale bar and the solid scale bar are representative of the stratum basale and ORS, respectively. Scale
bars¼ 100mm. (e) NHEKs, stained with the human anti-GW182 serum, 18033 (green), are shown on the left.
Arrows indicate select GW bodies. A control, stained with secondary antibody only, is shown on the right.
The nuclei were counterstained with 40,6-diamidino-2-phenylindole (DAPI, blue). Scale bar¼10mm.
Abbreviations: NHEK, normal human epidermal keratinocyte; RNAi, RNA interference
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and the apocrine glands demonstrated
weak and sparse staining, respectively
(data not shown). Depending on the
number and size of GWBs, fluorescence
intensity varied and was measured
semi-quantitatively (refer to Table 1).
Immunohistochemical studies were
also performed on serial formalin-fixed,
paraffin-embedded skin sections using
a mouse mAb to the proliferation marker
Ki67 (Dako, Glostrup, Denmark).
Within the GWB-containing structures
of skin, Ki67-positive cells were noted
(Figure S3). Accordingly, GWBs appear
more prominent in the proliferative cell
populations of normal skin.
To determine whether the GWBs
within normal human keratinocytes con-
tain proteins involved in mRNA degrada-
tion and RNAi, colocalization studies
were performed using antibodies to
LSm4, Xrn1, Ge-1 (also known as
RCD8 or Hedls), Argonaute-2 (Ago2),
and Dicer. Normal human epidermal
keratinocytes (NHEK) (Cascade Biologics,
Portland, OR) were cultured in EpiLife
medium containing human keratinocyte
growth supplement (Cascade Biologics).
For indirect immunofluorescence studies,
the cells were grown at 37 1C with 5%
CO2 to B60% confluency on 18mm
glass coverslips. As previously described,
the colocalization experiments were
carried out on NHEKs fixed with 2%
paraformaldehyde, permeabilized with
0.5% Triton X-100, and stained using
the following antibodies: a human
anti-GW182 serum, 18033 (Mitogen
Advanced Diagnostics Laboratory,
University of Calgary, Calgary, AB,
Canada), a mouse anti-Ago2 (a gift from
Dr E. Chan, University of Florida), a
mouse anti-Dicer, a chicken anti-LSm4
(Abcam, Cambridge, MA), a rabbit anti-
Ge-1 (a gift from Dr D. Bloch, Harvard
University), a rabbit anti-Xrn1 (Bethyl
Laboratories, Montgomery, TX), and
a mouse monoclonal anti-golgin97
(Mitogen Advanced Diagnostics Labo-
ratory, University of Calgary) (Jakymiw
et al., 2005; Moser et al., 2007). To
quantify the relative frequency of GWBs
colocalizing with the mRNA degradation
and RNAi-specific markers, Imaris 4.3.1
software (Bitplane Inc, Saint Paul, MN)
was used to enumerate both complete
and partial overlapping foci. As the
staining patterns demonstrated cellular
heterogeneity, the calculated percen-
tages of colocalization were obtained
from three to six keratinocytes observed
over duplicate independent experiments.
The GWBs of NHEKs varied in both
size and number (Figure 1e). Visualiza-
tion of the nucleus with 40,6-diamidino-
2-phenylindole (DAPI) confirmed their
cytoplasmic localization. A select group
of proteins involved in mRNA degrada-
tion and RNAi was found to colocalize
with keratinocyte GWBs, including
Ago2, Dicer, Ge-1, LSm4, and Xrn1
(Figure 2). Approximately 85.17, 18.95,
12.57, and 11.45% of GWBs co-stained
with antibodies to Ge-1, Xrn1, LSm4,
and Ago2, respectively. To a lesser
degree, Dicer colocalized with GW182
at a relative frequency of 2.49% (Table 2).
Cells stained with anti-golgin97 (a mAb
specific for the Golgi complex protein,
golgin97) and secondary antibody
alone had colocalization values of
0.19 and 0.80%, respectively, thus
demonstrating the specificity of our
findings in NHEKs.
Our data clearly demonstrate that
GWBs contain Ge-1, a protein that
enhances mRNA decapping and exo-
nuclease activity within the 50–30 mRNA
degradation pathway (Yu et al., 2005).
The lower colocalization frequencies
Table 1. The semi-quantitative evaluation of fluorescence intensity for
GWBs in normal human skin1
Structure Fluorescence intensity
Epidermis
Stratum basale +++
Stratum spinosum 
Stratum granulosum 
Stratum corneum 
Eccrine sweat gland
Secretory coil ++
Clear cells ++
Dark (intercalated) cells +
Myoepithelial cells 
Duct 
Apocrine sweat gland
Superficial secretory cells /+ uneven labeling
Basal cells 
Myoepithelial cells 
Duct 
Sebaceous gland
Basal cells ++
Mature sebocytes 
Hair follicle
Inner epidermal root sheath
Matrix +
Mature 
Outer epidermal root sheath2
Basal cell layer +++
Spinous cell layer 
1The fluorescence intensities were scored on a 4-point scale:  (negative), + (weak), ++ (moderate),
and +++ (strong).
2The portion below the entry of the sebaceous duct. The external root sheath above the duct entry
exhibited a pattern similar to that of the stratum basale.
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with Xrn1, LSm4, Ago2, and Dicer
suggest that there is microheterogeneity
in the compartmentalization of cuta-
neous GWBs, but that the latter are
more involved in mRNA degradation
and storage. Alternatively, the associa-
tion of GWBs and the mRNA degrada-
tion and/or RNAi proteins may be
transient and cell cycle-dependent. For
instance, in HeLa and HEp-2 cell lines,
GWBs have been previously shown to
vary in both size and number in relation
to cell cycle phase (Yang et al., 2004;
Lian et al., 2006).
The identification of cytoplasmic
GWBs in normal human skin has far-
reaching implications. Their involve-
ment in mRNA storage, regulation, and
cell proliferation suggests that GWBs
have a functional role in normal human
keratinocytes. Further investigations are
urgently required to study their signifi-
cance in skin homeostasis, repair, and
disease.
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Figure 2. GW bodies colocalize with mRNA degradation and RNAi-associated proteins in normal human epidermal keratinocytes (NHEK). Using indirect
immunofluorescence (IIF) techniques, GWBs were stained with the human anti-GW182 serum 18033 and the secondary AF488 antibody (green; column II).
Mouse anti-Ago2 antibody (neat), mouse anti-Dicer antibody (1:100), rabbit anti-Ge-1 antibody (1:400), chicken anti-LSm4 antibody (1:2), and rabbit
anti-Xrn1 antibody (1:2) were stained with the secondary AF568 antibody (red; column III). Images were merged and the nuclei were counterstained with
DAPI (columns I, IV). Merged images were enlarged in columns II–IV to illustrate the colocalization between GWBs and mRNA degradation/RNAi-associated
proteins in NHEKs. Arrows indicate select foci of colocalization.
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SUPPLEMENTARY MATERIAL
Figure S1. GW bodies colocalize with keratin 15
in the follicular bulge progenitor cells.
Figure S2. The distribution of GW bodies in
normal human skin.
Figure S3. GW bodies localize to regions contain-
ing highly proliferative Ki67-positive cells.
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with GW182 (%)
Ago2 An endonuclease that associates with miRNAs and siRNAs within the
RISC
11.45
Dicer A multi-domain RNase III enzyme responsible for cleaving long ds
RNA molecules into siRNAs of 19–21bp and processing premiRNAs
into their mature miRNA form
2.49
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